GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020

CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and financial results for the year ended December 31, 2020.

Click to view original post

Advertise With Us